You are invited to join the UK Dementia Research Institute at Imperial College London for the first instalment of their newly-launched seminar series.
Refershements will be available from 14:30.
Using epidemiology to guide discovery: Repurposing drugs to prevent dementia
Dr. Lenore J. Launer Senior Investigator, Chief, Neuroepidemiology Section Intramural Research Program, National Institute on Aging, NIH
Basing drug target identification on observational epidemiologic cohort studies has many unique advantages that complement other strategies for drug discovery. The case of hypertension as a risk factor for Alzheimer’s disease provides an example of using observational epidemiologic data to identify drugs that reduce AD risk. A brief overview will be given on blood pressure-brain epidemiologic and trial findings, as well as methodologic issues in studying these relationships. Preliminary data will be presented from a meta-analysis of population-based follow-up studies examining the risk for dementia associated various anti-hypertensive medications.
If you have any queries, please contact: Dr. Maksym Kopanitsa (m.kopanitsa@imperial.ac.uk)